drugset / Trial / NCT05301504
A Study in Tanzania of a New Vaccine Against Two Types of Ebola
Non-randomizedSequentialOpen-labelPrevention
Summary
An open label, first in human, non-randomised, dose escalation, single centre, phase Ib clinical trial
Timeline
- Start
- 2022-03-30
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ChAdOx1 biEBOV | Vaccine | 5e+09 unknown | Intramuscular |
| Subject | ChAdOx1 biEBOV | Vaccine | 2.5e+10 unknown | Intramuscular |
| Subject | ChAdOx1 biEBOV | Vaccine | 5e+10 unknown | Intramuscular |